Aprea Therapeutics, Inc. (APRE) vs Senti Biosciences, Inc. (SNTI)
Aprea Therapeutics, Inc. and Senti Biosciences, Inc. are both Biotechnology companies. Aprea Therapeutics, Inc. and Senti Biosciences, Inc. are of similar size ($10.0M and $9.8M). Senti Biosciences, Inc. grew revenue faster over the last twelve months: −70.7% against −81.0%. Aprea Therapeutics, Inc. has the higher net margin (0.00% vs −3,789.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Aprea Therapeutics, Inc. leads on 9 and Senti Biosciences, Inc. on 4.
Valuation
Profitability
| Metric | APRE | SNTI | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (4,181.12%) | 0.00% |
| Net margin | 0.00% | (3,789.30%) | 0.00% |
| Free cash flow margin | 0.00% | (2,900.38%) | 0.00% |
| Return on equity | (47.44%) | (466.46%) | (57.72%) |
| Return on assets | (41.30%) | (97.52%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack